吉林長龍藥業：環境、社會及管治報告2021.pdf

1、Environmental,Social and Governance Report2 0 2 1環境、社會及管治報告吉林省輝南長龍生化藥業股份有限公司二零二一年環境、社會及管治報告1ENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT環境、社會及管治報告ABOUT THE REPORTJilin Province Huinan Changlong Bio-pharmacy Company Limited(the“Company”)and its subsidiaries(collectively referred to as the“Group”)is com

2、mitted to the long-term sustainability of its businesses and the communities with which it engages.The Group pursues this business approach by managing its businesses prudently and executing management decisions with due care and attention.In addition,the Group is committed to improving its environm

3、ental,social and governance(“ESG”)performance by upholding good corporate governance standards,protecting the environment,engaging the community and promoting social integration.Scope of the ESG ReportThis ESG report(the“ESG Report”)discloses the Groups ESG management approach and performance during

4、 the financial year from 1 January 2021 to 31 December 2021(the“Reporting Period”)and explains how the Group complies with the“comply or explain”provisions of the Environmental,Social and Governance Reporting Guide(“ESG Reporting Guide”)in Appendix 20 to the Rules Governing the Listing of Securities

5、(the“Listing Rules”)on The Stock Exchange of Hong Kong Limited(the“Stock Exchange”).Reporting Principles Materiality Materiality assessment was conducted to diagnose material issues during the Reporting Period.Materiality of issues was reviewed by the board of directors(“Board”or“Board of Directors”

6、)of the Company and senior management of the Group.Quantitative The standards and methodologies used in the calculation of relevant data,as well as the assumptions used were disclosed in this ESG Report.Consistency The preparation of this ESG Report was substantially consistent with the previous yea